Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company's planned public offering on the South Korean stock market (KOSDAQ) early next year. A number of new investors have joined the round including leading US healthcare investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, as well as Asia-based global healthcare investors Tybourne Capital Management, and NSG Ventures.

Following the most recent strategic investment of $26 million from Guardant Health, the company has now secured more than $135 million in total ahead of its planned KOSDAQ IPO next year SEOUL, South Korea, Nov. 25, 2021 /PRNewswire/ -- Combined with the pre-IPO round, the company has secured more than $135 million in total to date.

Medical Ai Provider Lunit Raises $61M In Funding Round Led By Major Global Healthcare Investors

Description

Company Information

Funding Insights

Medical Ai Provider Lunit Raises $61M In Funding Round Led By Major Global Healthcare Investors

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information